[The impact of molecular biology on psychiatric diseases].
Salín-Pascual
Rafael J
RJ
Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México. salin@servidor.unam.mx
Alcocer Castillejos
Natasha
N
D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D002352:Carrier Proteins / Q000187:drug effects / Q000235:genetics; D004200:Diseases in Twins / Q000235:genetics; D030342:Genetic Diseases, Inborn / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D006801:Humans; D008607:Intellectual Disability / Q000235:genetics; D001523:Mental Disorders / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D008967:Molecular Biology; D009419:Nerve Tissue Proteins / Q000187:drug effects / Q000235:genetics; D018377:Neurotransmitter Agents / Q000378:metabolism; D010551:Personality / Q000235:genetics; D010597:Pharmacogenetics; D011570:Psychiatry; D011619:Psychotropic Drugs / Q000493:pharmacokinetics / Q000627:therapeutic use; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000235:genetics; D018433:Twin Studies as Topic
D000928:Antidepressive Agents; D002352:Carrier Proteins; D009419:Nerve Tissue Proteins; D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs; D017981:Receptors, Neurotransmitter